0001209191-19-050309.txt : 20190920
0001209191-19-050309.hdr.sgml : 20190920
20190920160204
ACCESSION NUMBER: 0001209191-19-050309
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190920
DATE AS OF CHANGE: 20190920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Currie Mark G
CENTRAL INDEX KEY: 0001478244
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38787
FILM NUMBER: 191104717
MAIL ADDRESS:
STREET 1: C/O CYCLERION THERAPEUTICS, INC.
STREET 2: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001755237
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831895370
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2019-04-01
2019-04-03
0
0001755237
Cyclerion Therapeutics, Inc.
CYCN
0001478244
Currie Mark G
C/O CYCLERION THERAPEUTICS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
President
Employee Stock Option (Right to Buy)
12.24
2019-04-01
4
A
0
37279
0.00
A
2021-02-01
Common Stock
37279
37279
D
Employee Stock Option (Right to Buy)
16.21
2019-04-01
4
A
0
17490
0.00
A
2022-02-01
Common Stock
17490
17490
D
Employee Stock Option (Right to Buy)
14.40
2019-04-01
4
A
0
27772
0.00
A
2023-02-01
Common Stock
27772
27772
D
Employee Stock Option (Right to Buy)
17.20
2019-04-01
4
A
0
2500
0.00
A
2025-03-01
Common Stock
2500
2500
D
Employee Stock Option (Right to Buy)
11.28
2019-04-01
4
A
0
50794
0.00
A
2026-03-01
Common Stock
50794
50794
D
Employee Stock Option (Right to Buy)
18.47
2019-04-01
4
A
0
113413
0.00
A
2027-02-27
Common Stock
113413
113413
D
Employee Stock Option (Right to Buy)
16.02
2019-04-01
4
A
0
140984
0.00
A
2028-02-21
Common Stock
140984
140984
D
Employee Stock Option (Right to Buy)
14.21
2019-04-01
4
A
0
514698
0.00
A
2029-01-29
Common Stock
514698
514698
D
This report has been amended to correct the exercise price of the stock options that were originally issued by Ironwood Pharmaceuticals, Inc. ("Ironwood") as a result of the spin-off of the Issuer from Ironwood, effective on April 1, 2019 ("the Separation").
This option, granted as an annual performance award, is presently exercisable in full.
This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation.
This footnote has been amended to reflect the number of unvested options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation. This option to purchase 25,208 shares vests in equal installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,500 shares as of the date hereof.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2016.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2017.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2018.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2019.
/s/ Larry Miller, Attorney-in-Fact
2019-09-20